Topics
- Overcoming mechanisms of drug resistance with new targeted anti-cancer therapies
- Strategies for the identification of selective kinase inhibitors
- DNA-targeted agents as part of a personalised approach to drug discovery
- New therapeutic targets in epigenetics and newly described metabolic pathways
- Engineering antibodies for targeted cancer therapy
- Methods for establishing pharmacologically safe and effective dose in animal studies
- Preparing for exploratory development
Who should Attend
Team Leaders, Research Scientists, Managers, Heads, professionals and Directors working in the following areas related to oncology::
- Preclinical Development
- Drug Discovery
- Medicinal Chemistry
- Exploratory Development
- Formulation
- Computational chemistry
- Translational Medicine
- Targeted therapeutics
- Genetics
- Personalised medicine
- Data Management
- Regulatory Affairs
- More Information:
